Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
暂无分享,去创建一个
E. Kang | B. Cha | Y. Choi | Eun Jig Lee | Byung-wan Lee | Gyuri Kim | K. Huh | Youngju Choi | B. W. Huh | Hokyou Lee | Y. Lee
[1] Enrico Barbieri,et al. Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes , 2012, Diabetes Care.
[2] S. Park,et al. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. , 2014, The Journal of clinical endocrinology and metabolism.
[3] William T. Clarke,et al. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes , 2016, Journal of the American College of Cardiology.
[4] Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.
[5] S. Malnick,et al. Non-alcoholic fatty liver disease - the heart of the matter. , 2015, World journal of hepatology.
[6] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[7] P. Rattanawong,et al. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis , 2017, European journal of gastroenterology & hepatology.
[8] Mats Fredrikson,et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.
[9] E. Bonora,et al. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes , 2015, PloS one.
[10] G. MacGowan,et al. Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control , 2015, Cardiovascular Diabetology.
[11] Enzo Bonora,et al. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.
[12] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[13] Sanjiv J. Shah,et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study , 2015, Hepatology.
[14] B. Howard,et al. Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study , 2002, Circulation.
[15] S. Goland,et al. Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.
[16] E. Han,et al. Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases , 2017, Diabetes & metabolism journal.
[17] E. Kang,et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. , 2017, Journal of hepatology.
[18] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[19] Tolga Yakar,et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. , 2010, Cardiology journal.
[20] V. Wong,et al. NAFLD in Asia—as common and important as in the West , 2013, Nature Reviews Gastroenterology &Hepatology.
[21] G. Cho,et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population , 2014, Heart.
[22] James B Seward,et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.
[23] A. Nicolini,et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt , 2006, Gut.
[24] A. DeMaria,et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.
[25] R. Farah,et al. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. , 2010, Radiology.
[26] H. Hense,et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. , 2003, European heart journal.
[27] Herbert Tilg,et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases , 2017, Gut.
[28] M. Watt,et al. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance , 2017, Nature Reviews Endocrinology.
[29] Rohit Loomba,et al. The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.
[30] C. Zancanaro,et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. , 1989, The Journal of clinical endocrinology and metabolism.
[31] G. Habib,et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.
[32] P. Poirier,et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. , 2001, Diabetes care.
[33] Thomas H Marwick,et al. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.
[34] G. Lopaschuk,et al. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. , 2012, American journal of physiology. Endocrinology and metabolism.
[35] P. Scifo,et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver , 2007, Hepatology.
[36] Casper G. Schalkwijk,et al. Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008 .
[37] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[38] J. Sowers,et al. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.
[39] G. Marchesini,et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. , 2015, Journal of hepatology.
[40] E. Kang,et al. Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes , 2015, Cardiovascular Diabetology.
[41] Z. Younossi,et al. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[42] R. Chung,et al. Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction , 2017, Obesity.
[43] A. DeMaria,et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .